Which sarcoma cancer patients can personalised medicine help?
Medical Doctor and PhD Ninna Aggerholm-Pedersen from Aarhus University and Aarhus University Hospital has been awarded the Danish Cancer Society’s Young Talented Researcher Grant of DKK 2.3 million for her research into which sarcoma cancer patients can benefit from personalised medicine.
Ninna Aggerholm-Pedersen analyses genetic changes in patients who have been diagnosed with sarcoma cancer – that is to say, patients with cancer tumours that emanate from connective tissue, bones, muscles or other supporting tissue.
The genetic analysis identifies the sarcoma patients who would benefit from being offered targeted treatment or, as it is also known, personalised medicine. In the long term, the analysis may help to determine which patients are suitable for treatment with personalised medicine.
Expectations are that many sarcoma patients will benefit from the genetic analysis and the subsequent targeted option of personalised medicine at an early stage of the cancer treatment, and also at an earlier stage than current normal practice.